Rate My Professor Emily Oates

Oates' research specializations encompass the discovery of new human disease genes, particularly in neuromuscular and rare diseases; assessment of disease-causing mutation effects at clinical, RNA transcript, protein, and tissue levels; enhancement of genetic diagnosis rates for patients and families; delineation of clinical characteristics, natural history, and pathogenesis of genetic disorders; and development of potential new therapies. Her academic interests include genetics, genomics, transcriptomics, RNA sequencing, whole genome sequencing, diagnostics and disease characterisation, striated muscle biology, and titinopathies arising from TTN gene variants. She has secured major National Health and Medical Research Council funding, including a $2.5 million Ideas Grant in 2022 and a $3 million Ideas Grant in 2023, to improve health outcomes for Australians with genetic neurological diseases. Key publications include 'Congenital Titinopathy: Comprehensive Characterization and Pathogenic Insights' (Annals of Neurology, 2018), 'Mutations in BICD2 Cause Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraplegia' (American Journal of Human Genetics, 2013), 'Improving Genetic Diagnosis in Mendelian Disease with Transcriptome Sequencing' (Science Translational Medicine, 2017), and 'Genome and RNA Sequencing Boost Neuromuscular Diagnoses to 62% from 34% with Exome Sequencing Alone' (Annals of Clinical and Translational Neurology, 2024). Her contributions have advanced diagnostic genomics, significantly increasing yield through multi-omics integration and informing therapeutic strategies for rare neuromuscular conditions.